Global (United States, European Union and China) Voriconazole Market Research Report 2019-2025

Table of Contents

1 Voriconazole Market Overview

• 1.1 Product Overview and Scope of Voriconazole
• 1.2 Voriconazole Segment by Type
  • 1.2.1 Global Voriconazole Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Injection
  • 1.2.3 Freeze-dried Powder
• 1.3 Voriconazole Segment by Application
  • 1.3.1 Voriconazole Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Global Voriconazole Market Size Estimates and Forecasts
  • 1.4.1 Global Voriconazole Revenue 2015-2026
  • 1.4.2 Global Voriconazole Sales 2015-2026
  • 1.4.3 Voriconazole Market Size by Region: 2020 Versus 2026

2 Global Voriconazole Market Competition by Manufacturers

• 2.1 Global Voriconazole Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Voriconazole Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Voriconazole Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Voriconazole Manufacturing Sites, Area Served, Product Type
• 2.5 Voriconazole Market Competitive Situation and Trends
  • 2.5.1 Voriconazole Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Voriconazole Players (Opinion Leaders)

3 Voriconazole Retrospective Market Scenario by Region

• 3.1 Global Voriconazole Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Voriconazole Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Voriconazole Market Facts & Figures by Country
  • 3.3.1 North America Voriconazole Sales by Country
  • 3.3.2 North America Voriconazole Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Voriconazole Market Facts & Figures by Country
  • 3.4.1 Europe Voriconazole Sales by Country
  • 3.4.2 Europe Voriconazole Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Voriconazole Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Voriconazole Sales by Region
  • 3.5.2 Asia Pacific Voriconazole Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Voriconazole Market Facts & Figures by Country
  • 3.6.1 Latin America Voriconazole Sales by Country
  • 3.6.2 Latin America Voriconazole Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Voriconazole Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Voriconazole Sales by Country
  • 3.7.2 Middle East and Africa Voriconazole Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Voriconazole Historic Market Analysis by Type

• 4.1 Global Voriconazole Sales Market Share by Type (2015-2020)
• 4.2 Global Voriconazole Revenue Market Share by Type (2015-2020)
• 4.3 Global Voriconazole Price Market Share by Type (2015-2020)
• 4.4 Global Voriconazole Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Voriconazole Historic Market Analysis by Application

• 5.1 Global Voriconazole Sales Market Share by Application (2015-2020)
• 5.2 Global Voriconazole Revenue Market Share by Application (2015-2020)
• 5.3 Global Voriconazole Price by Application (2015-2020)

6 Company Profiles and Key Figures in Voriconazole Business

• 6.1 Pfizer
  • 6.1.1 Corporation Information
  • 6.1.2 Pfizer Description, Business Overview and Total Revenue
  • 6.1.3 Pfizer Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Pfizer Products Offered
  • 6.1.5 Pfizer Recent Development
• 6.2 Teva
  • 6.2.1 Teva Voriconazole Production Sites and Area Served
  • 6.2.2 Teva Description, Business Overview and Total Revenue
  • 6.2.3 Teva Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Teva Products Offered
  • 6.2.5 Teva Recent Development
• 6.3 GeneTech Pharm
  • 6.3.1 GeneTech Pharm Voriconazole Production Sites and Area Served
  • 6.3.2 GeneTech Pharm Description, Business Overview and Total Revenue
  • 6.3.3 GeneTech Pharm Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 GeneTech Pharm Products Offered
  • 6.3.5 GeneTech Pharm Recent Development
• 6.4 Novartis
  • 6.4.1 Novartis Voriconazole Production Sites and Area Served
  • 6.4.2 Novartis Description, Business Overview and Total Revenue
  • 6.4.3 Novartis Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Novartis Products Offered
  • 6.4.5 Novartis Recent Development
• 6.5 Mylan
  • 6.5.1 Mylan Voriconazole Production Sites and Area Served
  • 6.5.2 Mylan Description, Business Overview and Total Revenue
  • 6.5.3 Mylan Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Mylan Products Offered
  • 6.5.5 Mylan Recent Development
• 6.6 Squibb
  • 6.6.1 Squibb Voriconazole Production Sites and Area Served
  • 6.6.2 Squibb Description, Business Overview and Total Revenue
  • 6.6.3 Squibb Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Squibb Products Offered
  • 6.6.5 Squibb Recent Development
• 6.7 Sandoz
  • 6.6.1 Sandoz Voriconazole Production Sites and Area Served
  • 6.6.2 Sandoz Description, Business Overview and Total Revenue
  • 6.6.3 Sandoz Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Sandoz Products Offered
  • 6.7.5 Sandoz Recent Development
• 6.8 Daiichi Sankyo
  • 6.8.1 Daiichi Sankyo Voriconazole Production Sites and Area Served
  • 6.8.2 Daiichi Sankyo Description, Business Overview and Total Revenue
  • 6.8.3 Daiichi Sankyo Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Daiichi Sankyo Products Offered
  • 6.8.5 Daiichi Sankyo Recent Development
• 6.9 GSK
  • 6.9.1 GSK Voriconazole Production Sites and Area Served
  • 6.9.2 GSK Description, Business Overview and Total Revenue
  • 6.9.3 GSK Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 GSK Products Offered
  • 6.9.5 GSK Recent Development
• 6.10 Cilag AG
  • 6.10.1 Cilag AG Voriconazole Production Sites and Area Served
  • 6.10.2 Cilag AG Description, Business Overview and Total Revenue
  • 6.10.3 Cilag AG Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Cilag AG Products Offered
  • 6.10.5 Cilag AG Recent Development
• 6.11 Macherey-Nagel GmbH
  • 6.11.1 Macherey-Nagel GmbH Voriconazole Production Sites and Area Served
  • 6.11.2 Macherey-Nagel GmbH Voriconazole Description, Business Overview and Total Revenue
  • 6.11.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 Macherey-Nagel GmbH Products Offered
  • 6.11.5 Macherey-Nagel GmbH Recent Development
• 6.12 Abbott
  • 6.12.1 Abbott Voriconazole Production Sites and Area Served
  • 6.12.2 Abbott Voriconazole Description, Business Overview and Total Revenue
  • 6.12.3 Abbott Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.12.4 Abbott Products Offered
  • 6.12.5 Abbott Recent Development
• 6.13 Takeda
  • 6.13.1 Takeda Voriconazole Production Sites and Area Served
  • 6.13.2 Takeda Voriconazole Description, Business Overview and Total Revenue
  • 6.13.3 Takeda Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.13.4 Takeda Products Offered
  • 6.13.5 Takeda Recent Development
• 6.14 Sichuan Beauty Sport Huakang Pharmaceutical
  • 6.14.1 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Production Sites and Area Served
  • 6.14.2 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Description, Business Overview and Total Revenue
  • 6.14.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.14.4 Sichuan Beauty Sport Huakang Pharmaceutical Products Offered
  • 6.14.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Development
• 6.15 Jincheng HEALTH Pharmaceutical
  • 6.15.1 Jincheng HEALTH Pharmaceutical Voriconazole Production Sites and Area Served
  • 6.15.2 Jincheng HEALTH Pharmaceutical Voriconazole Description, Business Overview and Total Revenue
  • 6.15.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.15.4 Jincheng HEALTH Pharmaceutical Products Offered
  • 6.15.5 Jincheng HEALTH Pharmaceutical Recent Development
• 6.16 Ebang Pharmaceutical
  • 6.16.1 Ebang Pharmaceutical Voriconazole Production Sites and Area Served
  • 6.16.2 Ebang Pharmaceutical Voriconazole Description, Business Overview and Total Revenue
  • 6.16.3 Ebang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.16.4 Ebang Pharmaceutical Products Offered
  • 6.16.5 Ebang Pharmaceutical Recent Development
• 6.17 Aditya Pharma
  • 6.17.1 Aditya Pharma Voriconazole Production Sites and Area Served
  • 6.17.2 Aditya Pharma Voriconazole Description, Business Overview and Total Revenue
  • 6.17.3 Aditya Pharma Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.17.4 Aditya Pharma Products Offered
  • 6.17.5 Aditya Pharma Recent Development
• 6.18 Taj Pharmaceuticals
  • 6.18.1 Taj Pharmaceuticals Voriconazole Production Sites and Area Served
  • 6.18.2 Taj Pharmaceuticals Voriconazole Description, Business Overview and Total Revenue
  • 6.18.3 Taj Pharmaceuticals Voriconazole Sales, Revenue and Gross Margin (2015-2020)
  • 6.18.4 Taj Pharmaceuticals Products Offered
  • 6.18.5 Taj Pharmaceuticals Recent Development

7 Voriconazole Manufacturing Cost Analysis

• 7.1 Voriconazole Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Voriconazole
• 7.4 Voriconazole Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Voriconazole Distributors List
• 8.3 Voriconazole Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Voriconazole Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Voriconazole by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Voriconazole by Type (2021-2026)
• 10.2 Voriconazole Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Voriconazole by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Voriconazole by Application (2021-2026)
• 10.3 Voriconazole Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Voriconazole by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Voriconazole by Region (2021-2026)
• 10.4 North America Voriconazole Estimates and Projections (2021-2026)
• 10.5 Europe Voriconazole Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Voriconazole Estimates and Projections (2021-2026)
• 10.7 Latin America Voriconazole Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Voriconazole Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List